Product Information
MEXILETINE 250 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4464 per EA under NDC 64980066801. Its NADAC has been published 44 times since Aug 27, 2025.
Strength
250 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980066801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215315On Market Since
2/5/2025
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 250 MG CAPSULE has been published 44 times since Aug 27, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4464 per EA |
|---|---|
| All-time high | $0.4943 (Apr 15, 2026) |
| All-time low | $0.4101 (Nov 19, 2025) |
| 52-week high | $0.4943 |
| 52-week low | $0.4101 |
| Median price | $0.4464 |
| Average price | $0.4478 |
| Largest weekly change | +8.3% (Jan 21, 2026) |
| Weeks tracked | 44 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEXILETINE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 250 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.4464 per EA (NDC 64980066801), effective Jun 24, 2026.
How has the price of MEXILETINE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 250 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 44 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for MEXILETINE 250 MG CAPSULE?
Since Aug 27, 2025, the NADAC for MEXILETINE 250 MG CAPSULE has ranged from a low of $0.4101 (Nov 19, 2025) to a high of $0.4943 (Apr 15, 2026), with a median of $0.4464 per EA.
Are there cheaper alternatives to MEXILETINE 250 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as MEXILETINE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures MEXILETINE 250 MG CAPSULE?
MEXILETINE 250 MG CAPSULE (NDC 64980066801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification